Blood News and Research

RSS

Study explains large geographic health disparities in the U.S.

60% of American adults have a chronic condition, but adults in Mississippi are 50% more likely to have one than adults in Colorado.

15 Oct 2020

Certain live-attenuated vaccines can prevent severe complications of COVID-19

COVID-19 continues to wreak havoc globally, with over one million deaths to date. Yet what if an existing vaccine could make COVID-19 less deadly? A study just published put the theory to test, with promising results.

15 Oct 2020

Study may lead to new therapies to improve survival in septic patients

Each year, some 270,000 Americans die from sepsis, in which the release of normally helpful infection-fighting chemicals in the body triggers an unusually extreme immune response - powerful enough to cause life-threatening damage to blood vessels and organs.

15 Oct 2020

New saliva tests can enable early detection and diagnosis of COVID-19, head & neck cancer

Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced today a broad strategic collaboration involving research, development and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions.

15 Oct 2020

Researchers reveal potential mechanisms behind the healing power of extracellular vesicles

Extracellular vesicles (EVs) -- nanometer sized messengers that travel between cells to deliver cues and cargo -- are promising tools for the next generation of therapies for everything from autoimmune and neurodegenerative diseases to cancer and tissue injury.

15 Oct 2020

Pharmacist-led digital intervention associated with reduced rates of hazardous prescribing

A pharmacist-led, new digital intervention that improves patient safety when prescribing medication in general practice reduced rates of hazardous prescribing by more than 40 per cent, 12 months after it had been introduced to 43 GP practices in Salford, finds a new study.

14 Oct 2020

People born with a heart defect have low risk of moderate or severe COVID-19 infection

Results of a retrospective analysis suggest that people born with a heart defect who developed COVID-19 symptoms had a low risk of moderate or severe COVID-19 infection, according to a new article published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.

14 Oct 2020

Researchers are working to advance device for detecting ultra-low levels of disease particles

In Judith Su's Little Sensor Lab, researchers are working to sense tiny amounts - down to a single molecule - of everything from doping agents to biomarkers for cancer, Alzheimer's disease, Lyme disease and, yes, even COVID-19.

14 Oct 2020

Women with undiagnosed heart conditions at risk for pregnancy-related aortic dissection

In a time already full of challenges and changes, some pregnant and postpartum women will also experience a rare but dangerous heart complication: an aortic dissection.

14 Oct 2020

Maltreatment at early age affects girls more than boys

New research by a University of Georgia scientist reveals that girls who are maltreated show higher levels of inflammation at an early age than boys who are maltreated or children who have not experienced abuse. This finding may forecast chronic mental and physical health problems in midlife.

14 Oct 2020

The COVID-19 vaccine pipeline

Researchers from Mayo Clinic, United States of America, have reviewed the immunity developed against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 disease.

14 Oct 2020

Researchers develop breakthrough blood test for brain tumors

Genetic mutations that promote the growth of the most common type of adult brain tumors can be accurately detected and monitored in blood samples using an enhanced form of liquid biopsy developed by researchers at Massachusetts General Hospital.

14 Oct 2020

FDA approves Regeneron antibody drug as first treatment for Ebola virus

Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients.

14 Oct 2020

Blood News and Research

Study explains large geographic health disparities in the U.S.

Certain live-attenuated vaccines can prevent severe complications of COVID-19

Study may lead to new therapies to improve survival in septic patients

New saliva tests can enable early detection and diagnosis of COVID-19, head & neck cancer

Researchers reveal potential mechanisms behind the healing power of extracellular vesicles

Pharmacist-led digital intervention associated with reduced rates of hazardous prescribing

People born with a heart defect have low risk of moderate or severe COVID-19 infection

Researchers are working to advance device for detecting ultra-low levels of disease particles

Women with undiagnosed heart conditions at risk for pregnancy-related aortic dissection

Maltreatment at early age affects girls more than boys

The COVID-19 vaccine pipeline

Researchers develop breakthrough blood test for brain tumors

FDA approves Regeneron antibody drug as first treatment for Ebola virus

Scientists find sensor protein that makes normal bladder function possible

Army researchers team up to test alternative ways to measure COVID-19 antibody levels

Researchers receive $11 million grant to study factors involved in multi-drug resistant infections

Research identifies antigen-specific peripheral T follicular helper cells in COVID-19 infected patients

Anti-inflammatory drugs may hold the potential to alleviate Parkinson's disease, study suggests

Characterization of prognostic markers to predict COVID-19 severity

'Shrinking' tonsils results in lesser pain and bleeding than full tonsillectomy

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News